Short Interest in HLS Therapeutics Inc. (OTCMKTS:HLTRF) Declines By 96.9%

HLS Therapeutics Inc. (OTCMKTS:HLTRF) was the recipient of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 100 shares, a decrease of 96.9% from the March 15th total of 3,200 shares. Based on an average daily volume of 1,400 shares, the days-to-cover ratio is presently 0.1 days.

HLS Therapeutics Price Performance

OTCMKTS HLTRF remained flat at $2.96 during midday trading on Tuesday. 100 shares of the company’s stock traded hands, compared to its average volume of 941. The stock has a fifty day moving average of $2.99 and a two-hundred day moving average of $2.75. HLS Therapeutics has a 52 week low of $2.22 and a 52 week high of $3.56.

About HLS Therapeutics

HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.